Researchers reveal that consumption of fish oil supplements and probiotics during pregnancy might reduce the risk of food allergy or eczema in the child, according to a study conducted on February 28, 2018.
Researchers found that women who consumed a fish capsule daily from 20 weeks of pregnancy shows a 30 percent reduction in the risk of egg allergy in the child. A 22 percent reduction in the risk of child developing eczema was observed in women who consumed probiotic supplement when they were 36 to 38 weeks pregnant. Many dietary factors during pregnancy were assessed by the researchers and found that these factors does not affect allergy or eczema risk.
Dr. Robert Boyle, lead author of the research said, “Our research suggests probiotic and fish oil supplements may reduce a child’s risk of developing an allergic condition, and these findings need to be considered when guidelines for pregnant women are updated.”
In this study, 6,000 pregnant women who consumed probiotic supplements were assessed by carrying out 28 trials. Bacteria that is capable of naturally balancing the bugs in the gut were present in probiotics. Similarly, women who consumed fish oil supplements were also assessed by carrying out 19 trials. It was also observed that child’s risk of peanut allergy can also be reduced by consuming fish oil supplements. Breast feeding for longer duration was found to reduce the risk of eczema.
The Food Standards Agency funded this study and they advised people to follow the Government advice, which says that mother should only breastfeed the child till the age of six months. When the child is six months of age, they can be introduced to solid foods. According to the researchers, government dietary and supplement advice should be followed by the pregnant women.
Due to an increase in the consumption of probiotic supplement by pregnant women across the world, an increase in the growth of global clinical nutrition market can be observed, as detailed in the global clinical nutrition market report published by Coherent Market Insights.